These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 25463739)

  • 1. Persistent blood stream infection in patients supported with a continuous-flow left ventricular assist device is associated with an increased risk of cerebrovascular accidents.
    Trachtenberg BH; Cordero-Reyes AM; Aldeiri M; Alvarez P; Bhimaraj A; Ashrith G; Elias B; Suarez EE; Bruckner B; Loebe M; Harris RL; Zhang JY; Torre-Amione G; Estep JD
    J Card Fail; 2015 Feb; 21(2):119-25. PubMed ID: 25463739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are blood stream infections associated with an increased risk of hemorrhagic stroke in patients with a left ventricular assist device?
    Aggarwal A; Gupta A; Kumar S; Baumblatt JA; Pauwaa S; Gallagher C; Treitman A; Pappas P; Tatooles A; Bhat G
    ASAIO J; 2012; 58(5):509-13. PubMed ID: 22820918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The HVAD Left Ventricular Assist Device: Risk Factors for Neurological Events and Risk Mitigation Strategies.
    Teuteberg JJ; Slaughter MS; Rogers JG; McGee EC; Pagani FD; Gordon R; Rame E; Acker M; Kormos RL; Salerno C; Schleeter TP; Goldstein DJ; Shin J; Starling RC; Wozniak T; Malik AS; Silvestry S; Ewald GA; Jorde UP; Naka Y; Birks E; Najarian KB; Hathaway DR; Aaronson KD;
    JACC Heart Fail; 2015 Oct; 3(10):818-28. PubMed ID: 26450000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood stream infection is associated with cerebrovascular accident in patients with left ventricular assist device: a systematic review and meta-analysis.
    Kanjanahattakij N; Horn B; Abdulhadi B; Wongjarupong N; Mezue K; Rattanawong P
    J Artif Organs; 2018 Sep; 21(3):271-277. PubMed ID: 29546615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of concurrent surgical valve procedures in patients receiving continuous-flow devices.
    John R; Naka Y; Park SJ; Sai-Sudhakar C; Salerno C; Sundareswaran KS; Farrar DJ; Milano CA
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):581-9; discussion 589. PubMed ID: 24418362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of left ventricular assist device (HeartMate II): a Singapore experience.
    Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
    Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse neurologic events in patients bridged with long-term mechanical circulatory support: A device-specific comparative analysis.
    Coffin ST; Haglund NA; Davis ME; Xu M; Dunlay SM; Cowger JA; Shah P; Aaronson KD; Pagani FD; Stulak JM; Maltais S;
    J Heart Lung Transplant; 2015 Dec; 34(12):1578-85. PubMed ID: 26522376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients.
    Boyle AJ; Jorde UP; Sun B; Park SJ; Milano CA; Frazier OH; Sundareswaran KS; Farrar DJ; Russell SD;
    J Am Coll Cardiol; 2014 Mar; 63(9):880-8. PubMed ID: 24316083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrovascular accidents in patients with a ventricular assist device.
    Tsukui H; Abla A; Teuteberg JJ; McNamara DM; Mathier MA; Cadaret LM; Kormos RL
    J Thorac Cardiovasc Surg; 2007 Jul; 134(1):114-23. PubMed ID: 17599496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrovascular events in children on intracorporeal continuous-flow left ventricular assist devices.
    Sert DE; Kocabeyoglu SS; Kervan U; Karahan M; Beyazal OF; Akdi M; Yilmaz A; Catav Z
    Artif Organs; 2020 Dec; 44(12):1251-1258. PubMed ID: 32663321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo aortic regurgitation after continuous-flow left ventricular assist device implantation.
    Patil NP; Sabashnikov A; Mohite PN; Garcia D; Weymann A; Zych B; Bowles CT; Hards R; Hedger M; Popov AF; De Robertis F; Moza A; Bahrami T; Amrani M; Rahman-Haley S; Banner NR; Simon AR
    Ann Thorac Surg; 2014 Sep; 98(3):850-7. PubMed ID: 25069685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nosocomial bloodstream infections in patients with implantable left ventricular assist devices.
    Gordon SM; Schmitt SK; Jacobs M; Smedira NM; Goormastic M; Banbury MK; Yeager M; Serkey J; Hoercher K; McCarthy PM
    Ann Thorac Surg; 2001 Sep; 72(3):725-30. PubMed ID: 11565648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of early appropriate intervention including antibiotics and wound care for device-related infection in patients with left ventricular assist device.
    Hieda M; Sata M; Seguchi O; Yanase M; Murata Y; Sato T; Sunami H; Nakajima S; Watanabe T; Hori Y; Wada K; Hata H; Fujita T; Kobayashi J; Nakatani T
    Transplant Proc; 2014 Apr; 46(3):907-10. PubMed ID: 24767378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices.
    Kamdar F; John R; Eckman P; Colvin-Adams M; Shumway SJ; Liao K
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):575-81. PubMed ID: 23321132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era.
    Topkara VK; Kondareddy S; Malik F; Wang IW; Mann DL; Ewald GA; Moazami N
    Ann Thorac Surg; 2010 Oct; 90(4):1270-7. PubMed ID: 20868826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes after implantation of 139 full-support continuous-flow left ventricular assist devices as a bridge to transplantation.
    Sabashnikov A; Mohite PN; Weymann A; Patil NP; Hedger M; Sáez DG; Zych B; Wahlers T; Wippermann J; De Robertis F; Bahrami T; Amrani M; Simon AR; Popov AF
    Eur J Cardiothorac Surg; 2014 Nov; 46(5):e59-66. PubMed ID: 25180072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The spectrum of complications following left ventricular assist device placement.
    Yuan N; Arnaoutakis GJ; George TJ; Allen JG; Ju DG; Schaffer JM; Russell SD; Shah AS; Conte JV
    J Card Surg; 2012 Sep; 27(5):630-8. PubMed ID: 22978843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early elevations in pump power with the HeartMate II left ventricular assist device do not predict late adverse events.
    Salerno CT; Sundareswaran KS; Schleeter TP; Moanie SL; Farrar DJ; Walsh MN
    J Heart Lung Transplant; 2014 Aug; 33(8):809-15. PubMed ID: 24735680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.